Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Prime Medicine Inc (PRME)

Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Prime Medicine Inc 60 First Street Cambridge MA 02141 USA

https://primemedicine.com Employees: 146 P: 617-465-0013

Sector:

Medical

Description:

Prime Medicine Inc. is a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies. Prime Medicine Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 568,739
Enterprise Value, $K 505,709
Shares Outstanding, K 180,552
Float, K 139,494
% Float 77.26%
Short Interest, K 26,810
Short Float 14.85%
Days to Cover 9.84
Short Volume Ratio 0.35
% of Insider Shareholders 22.74%
% of Institutional Shareholders 70.37%

Financials:

Annual Sales, $ 4,630 K
Annual Net Income, $ -201,140 K
Last Quarter Sales, $ 840 K
Last Quarter Net Income, $ -46,080 K
EBIT, $ -208,350 K
EBITDA, $ -202,970 K

Growth:

1-Year Return 74.87%
3-Year Return -70.95%
5-Year Return 0.00%
5-Year Revenue Growth -11.13%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 03/03/26
Next Earnings Date 05/14/26
Earnings Per Share ttm -1.35
EPS Growth vs. Prev Qtr 31.25%
EPS Growth vs. Prev Year 29.03%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 09/10/19
Dividend Payable Date 09/12/19
Dividend Payout Ratio 0.00%

PRME Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -178.61%
Return-on-Assets % -60.27%
Profit Margin % -4,344.28%
Debt/Equity 0.00
Price/Sales 131.75
Price/Cash Flow N/A
Price/Book 5.05
Book Value/Share 0.67
Interest Coverage -2.84
60-Month Beta 2.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.